 |
Turna Ray is the editor of GenomeWeb's Pharmacogenomics Reporter. She covers pharmacogenomics, personalized medicine, and companion diagnostics. E-mail Turna Ray or follow her GenomeWeb Twitter account at @PGxReporter. |
Targeting Mid-Year LungExpress Dx Launch, Precision Readies Sales Force, Focuses on Reimbursement
January 23, 2013
Targeting Mid-Year LungExpress Dx Launch, Precision Readies Sales Force, Focuses on Reimbursement
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Med BioGene's 2012 Revenues Drop to Zero, as it Awaits Launch of NSCLC Test
April 9, 2013 / GenomeWeb Daily News - Dx Focus: Precision Therapeutics, Med BioGene LungExpress Dx; Hologic Prodesse ProGastro SSCS
January 24, 2013 / PCR Insider - Med BioGene Amends Licensing Deal with Precision; Updates Litigation Status
October 3, 2012 / GenomeWeb Daily News - Med BioGene Shareholders Approve Commercialization Deal with Precision Therapeutics
April 13, 2011 / GenomeWeb Daily News - Med BioGene Accepts Amended Offer from Precision Therapeutics
March 28, 2011 / GenomeWeb Daily News